DK22688A - POLYMER COMPLEXES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPLEXS - Google Patents

POLYMER COMPLEXES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPLEXS

Info

Publication number
DK22688A
DK22688A DK022688A DK22688A DK22688A DK 22688 A DK22688 A DK 22688A DK 022688 A DK022688 A DK 022688A DK 22688 A DK22688 A DK 22688A DK 22688 A DK22688 A DK 22688A
Authority
DK
Denmark
Prior art keywords
complexs
procedures
preparing
pharmaceutical agents
agents containing
Prior art date
Application number
DK022688A
Other languages
Danish (da)
Other versions
DK22688D0 (en
Inventor
Heinz Gries
Julius Deutsch
Erich Klieger
Ulrich Niedballa
Franz-Josef Renneke
Juergen Conrad
Wolfgang Muetzel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK22688D0 publication Critical patent/DK22688D0/en
Publication of DK22688A publication Critical patent/DK22688A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6887—Antibody-chelate conjugates using chelates for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
DK022688A 1987-01-19 1988-01-19 POLYMER COMPLEXES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPLEXS DK22688A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873701665 DE3701665A1 (en) 1987-01-19 1987-01-19 POLYMER COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Publications (2)

Publication Number Publication Date
DK22688D0 DK22688D0 (en) 1988-01-19
DK22688A true DK22688A (en) 1988-07-20

Family

ID=6319226

Family Applications (1)

Application Number Title Priority Date Filing Date
DK022688A DK22688A (en) 1987-01-19 1988-01-19 POLYMER COMPLEXES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPLEXS

Country Status (10)

Country Link
EP (1) EP0277088A2 (en)
JP (1) JPS6454028A (en)
AU (1) AU1064988A (en)
DE (1) DE3701665A1 (en)
DK (1) DK22688A (en)
IE (1) IE880127L (en)
IL (1) IL85139A0 (en)
NO (1) NO880179L (en)
PT (1) PT86572B (en)
ZA (1) ZA88342B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806795A1 (en) * 1988-02-29 1989-09-07 Schering Ag POLYMER-TIED COMPLEX IMAGERS, THEIR COMPLEXES AND CONJUGATES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THEM
US5681543A (en) * 1988-02-29 1997-10-28 Shering Aktiengesellschaft Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
FR2645862B1 (en) * 1989-04-18 1991-07-12 Esteve Labor Dr SUBSTITUTED ISOTHIAZOLO-PYRYDONE AZETIDINYL DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
US5384108A (en) * 1989-04-24 1995-01-24 Mallinckrodt Medical, Inc. Magnetic resonance imaging agents
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
DE3938992A1 (en) 1989-11-21 1991-05-23 Schering Ag Cascade polymer-bound complex formers, their complexes and conjugates, process for their preparation and pharmaceutical compositions containing them
DE4017439C2 (en) * 1990-05-30 1994-06-23 Deutsches Krebsforsch Polyether-substituted tumor agents
DE4039920A1 (en) * 1990-12-14 1992-06-17 Basf Ag NEW POLYETHYLENIMINE AND POLYVINYLAMINE DERIVATIVES, CARRIER MATERIALS COATED WITH THESE DERIVATIVES ON THE BASIS OF ALUMINUM AND THE USE THEREOF FOR THE PRODUCTION OF OFFSET PRINTING PLATES
JP2901787B2 (en) * 1991-07-15 1999-06-07 日本メジフィジックス株式会社 Nuclear magnetic resonance contrast agent
JP2894879B2 (en) * 1991-10-04 1999-05-24 日本メジフィジックス株式会社 Diagnostic contrast agent
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
WO1994008624A2 (en) * 1992-10-14 1994-04-28 Sterling Winthrop Inc. Therapeutic and diagnostic imaging compositions and methods
EP1419786A1 (en) 2002-11-13 2004-05-19 Bracco Imaging S.p.A. Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof
ITPD20030174A1 (en) * 2003-07-31 2003-10-29 Univ Padova POLYMERIC CONJUGATES FOR DIAGNOSTICS AND THERAPY
DE102005039154A1 (en) * 2005-08-17 2007-03-01 GÖPFERICH, Achim, Prof. Dr. Biodegradable polymers for the transport of nucleic acids into cells
MX2022014143A (en) 2020-05-12 2022-11-30 Basf Se Use of carboxymethylated polymer of lysines as dispersing agent and compositions comprising the same.

Also Published As

Publication number Publication date
ZA88342B (en) 1988-07-04
EP0277088A2 (en) 1988-08-03
JPS6454028A (en) 1989-03-01
IE880127L (en) 1988-07-19
PT86572B (en) 1991-12-31
PT86572A (en) 1988-02-01
NO880179D0 (en) 1988-01-18
NO880179L (en) 1988-07-20
DE3701665A1 (en) 1988-07-28
DK22688D0 (en) 1988-01-19
AU1064988A (en) 1988-07-21
IL85139A0 (en) 1988-06-30

Similar Documents

Publication Publication Date Title
DK654589D0 (en) HETEROCYCLIC DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
NO904584L (en) PREPARATIONS CONTAINING HYALURONIC ACID COMPOUNDS AND PROCEDURES FOR PREPARING THEREOF.
DK22688A (en) POLYMER COMPLEXES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPLEXS
DK128688D0 (en) THIAZOLD DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
DK219387D0 (en) AMINOTHIAZOL AND AMINOOXAZOLD DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK276189A (en) POLYPEPTIME RELATIONSHIPS, PROCEDURES FOR PREPARING THOSE PHARMACEUTICAL AGENTS CONTAINING THESE
DK378988D0 (en) DOPAMINE-BETA-HYDROXYLASE INHIBITORS, PROCEDURE FOR PREPARING IT, AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS
DK642588A (en) INDANDER DERIVATIVES, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK486789D0 (en) BENZOXAZOLINON DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK592189D0 (en) NITROIMIDAZOLES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK392284D0 (en) LH-RH ANTAGONISTS AND PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK66086D0 (en) DIHYDROPYRIDINES, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK162600C (en) OE4- (2-HYDROXYCYLOHEXYLMETHYL) PHENYLAALKANIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK567188A (en) 2,2-DIMETHYL CHROMINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THE DERIVATIVES
DK170788A (en) DIHYDROPYRIDAZINE DERIVATIVES, PROCEDURES FOR PREPARING IT, AND MEDICINES CONTAINING THESE
DK469189D0 (en) SUBSTITUTED THIENOPYRANES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
DK307085A (en) 4-PHENYL-2-TRIFLUORMETHYL-1,3-DIOXAN-5-YLHEPHENIC ACID DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK567184D0 (en) PYRIDONE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK2488D0 (en) DOPAMINE-BETA-HYDROXYLASE INHIBITORS, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK65986D0 (en) DIHYDROPYRIDINES, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK166686D0 (en) PHOSPHINE COMPOUNDS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS
DK268889A (en) CYCLIC D-CYS6 PEPTID RELATIONS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK165978C (en) 1-AMINOETHYL-1H-IMIDAZOLD DERIVATIVES, PROCEDURES FOR PREPARING IT, AND ANTIMYCOTIC AGENTS CONTAINING THESE
DK379287D0 (en) 1,3-PROPANDIAMINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE
DK564284D0 (en) PYRAZINO DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THESE

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment